Parker H Stewart

Insider Reports History

Entity
Company
Location
1100 Olive Way, Ste 100, Seattle, WA
Signature
/s/ Sriram Ryali, as Attorney-in-Fact for H. Stewart Parker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Parker H Stewart:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CODEXIS, INC. Director Common Stock 103K $216K $2.11 Jun 11, 2024 Direct
SANGAMO THERAPEUTICS, INC Director Common Stock 87.6K $52.6K $0.60 Jun 4, 2024 Direct
SANGAMO THERAPEUTICS, INC Director Stock Option (Right to Buy) 50K Jun 4, 2024 Direct
IMPEL PHARMACEUTICALS INC Director Stock Option (right to buy) 12.8K Jun 16, 2022 Direct

Insider Reports Filed by Parker H Stewart

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CDXS CODEXIS, INC. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
SGMO SANGAMO THERAPEUTICS, INC Jun 4, 2024 2 $0 4 Jun 6, 2024 Director
CDXS CODEXIS, INC. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
SGMO SANGAMO THERAPEUTICS, INC Jun 1, 2023 2 $0 4 Jun 5, 2023 Director
CDXS CODEXIS, INC. Dec 16, 2022 1 $0 4 Dec 20, 2022 Director
CDXS CODEXIS, INC. Dec 16, 2022 0 $0 3 Dec 20, 2022 Director
IMPL IMPEL PHARMACEUTICALS INC Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
SGMO SANGAMO THERAPEUTICS, INC Jun 1, 2022 1 $18K 4 Jun 3, 2022 Director
SGMO SANGAMO THERAPEUTICS, INC Feb 25, 2022 2 $0 4 Mar 1, 2022 Director
IMPL IMPEL NEUROPHARMA INC Jul 11, 2021 1 $0 4 Jul 13, 2021 Director
IMPL IMPEL NEUROPHARMA INC Apr 27, 2021 0 $0 4/A Jun 22, 2021 Director
IMPL IMPEL NEUROPHARMA INC Apr 22, 2021 0 $0 3/A Jun 22, 2021 Director